EUVIMEDEUVIMED entdecken
Open Access

Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis

Zelma C Chiesa Fuxench, Joy Wan, Sonia Wang, Maha N Syed, Daniel B Shin, Katrina Abuabara, Joel M Gelfand

JAMA Dermatology · 01.10.2023 · 159 (10) · 1085

DOI: 10.1001/jamadermatol.2023.2875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.10.2023. Verfasst von Zelma C Chiesa Fuxench und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Data on the association between atopic dermatitis (AD) and inflammatory bowel disease (IBD) are inconsistent. Few studies have examined the association of AD or AD severity with risk of ulcerative colitis (UC) and Crohn disease (CD) separately.

Objectives

To examine the risk of new-onset IBD, UC, and CD in children and adults with AD. Design, Setting, and Participants This population-based cohort study assessed patients with AD matched with up to 5 controls on age, practice, and index date. Treatment exposure was used as a proxy for AD severity. Data were retrieved from The Health Improvement Network, a UK electronic medical record database, for January 1, 1994, to February 28, 2015. Data analysis was performed from January 8, 2020, to June 30, 2023. Main Outcomes and Measures Outcomes of interest were incident IBD, UC, and CD. Logistic regression was used to examine the risk for each outcome in children and adults with AD compared with controls.

Results

A total of 1 809 029 pediatric controls were matched to 409 431 children with AD (93.2% mild, 5.5% moderate, and 1.3% severe). The pediatric cohort ranged in median age from 4 to 5 years (overall range, 1-10 years), was predominantly male (936 750 [51.8%] controls, 196 996 [51.6%] with mild AD, 11 379 [50.7%] with moderate AD, and 2985 [56.1%] with severe AD), and with similar socioeconomic status. A total of 2 678 888 adult controls were matched to 625 083 adults with AD (65.7% mild, 31.4% moderate, and 2.9% severe). The adult cohort ranged in median age from 45 to 50 years (overall range, 30-68 years) and was predominantly female (1 445 589 [54.0%] controls, 256 071 [62.3%] with mild AD, 109 404 [55.8%] with moderate AD, and 10 736 [59.3%] with severe AD). In fully adjusted models, children with AD had a 44% increased risk of IBD (hazard ratio [HR], 1.44; 95% CI, 1.31-1.58) and a 74% increased risk of CD (HR, 1.74; 95% CI, 1.54-1.97), which increased with worsening AD; however, they did not have increased risk of UC (HR, 1.09; 95% CI, 0.94-1.27) except for those with severe AD (HR, 1.65; 95% CI, 1.02-2.67). Adults with AD had a 34% (HR, 1.34; 95% CI, 1.27-1.40) increased risk of IBD, a 36% (HR, 1.36; 95% CI, 1.26-1.47) increased risk of CB, and a 32% (HR, 1.32; 95% CI, 1.24-1.41) increased risk of UC, with risk increasing with worsening AD. Conclusion and Relevance In this cohort study, children and adults with AD had an increased risk of IBD, with risk varying by age, AD severity, and IBD subtype. These findings provide new insights into the association between AD and IBD. Clinicians should be aware of these risks, particularly when selecting systemic treatments for AD in patients who may have coincident gastrointestinal symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicInflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseAdultHumansMaleFemaleChildInfantChild, PreschoolMiddle AgedAgedCohort StudiesRisk Factors

Autor:innen und Institutionen

  • Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.
  • Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Department of Dermatology, University of California, San Francisco.
  • Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Zitieren

APA

Chiesa Fuxench, Z. C., Wan, J., Wang, S., Syed, M. N., Shin, D. B., Abuabara, K., & Gelfand, J. M. (2023). Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis. JAMA Dermatology, 159(10), 1085. https://doi.org/10.1001/jamadermatol.2023.2875

Vancouver

Chiesa Fuxench ZC, Wan J, Wang S, Syed MN, Shin DB, Abuabara K, et al. Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis. JAMA Dermatology. 2023;159(10):1085. doi:10.1001/jamadermatol.2023.2875

BibTeX
@article{ChiesaFuxench2023,
  author = {Chiesa Fuxench, Zelma C and Wan, Joy and Wang, Sonia and Syed, Maha N and Shin, Daniel B and Abuabara, Katrina and Gelfand, Joel M},
  title = {Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis},
  journal = {JAMA Dermatology},
  year = {2023},
  volume = {159},
  number = {10},
  pages = {1085},
  doi = {10.1001/jamadermatol.2023.2875}
}
Kostenlos starten →